The story of Viagra, and its creator copyright, presents a intriguing case study for investors. At first a blockbuster drug, producing billions in revenue , its exclusivity period created a flood of generic competition , significantly diminishing its market share . While specific businesses may attempt to capitalize on similar conditions , the pres